Month: August 2025

Highly desirable Jaguar D-Type will be one of the highlights of Broad Arrow Zürich Auction in partnership with Auto Zürich on 1 November1956 Jaguar D-Type set to star at Broad Arrow’s inaugural Zurich AuctionCredit – Robin Möhl / Courtesy of Broad Arrow AuctionsThe unraced, highly original Jaguar D-Type set to star at Broad Arrow’s inaugural Zurich AuctionCredit – Robin Möhl / Courtesy of Broad Arrow AuctionsLONDON, England, Aug. 12, 2025 (GLOBE NEWSWIRE) —One of only 71 Jaguar D-Types produced Rare example that has never been used in competitive motorsport Matching engine and chassis numbers Meticulously cared for by current Swiss owner for past three decades Highly desirable Jaguar D-Type will be one of the highlights of Broad Arrow Zürich Auction in partnership with Auto Zürich...

Havila Kystruten AS has, in accordance with provisions in its LNG procurement agreement, renegotiated certain terms, enabling the company to source approximately one-third of its LNG volume directly from an alternative supplier in Northern Norway through 2030. This supplier sources LNG from the production facility at Melkøya, near Hammerfest. The revised agreement introduces a dual-supplier model and links part of the LNG pricing to gasoil, resulting in a more diversified fuel price indexation — with two-thirds linked to TTF and one-third to gasoil. This structure is expected to reduce exposure to fuel price volatility and enhance cost predictability. Combined with planned improvements to bunkering logistics in Northern Norway and a more competitive pricing formula compared to the current arrangement, the company anticipates annual fuel...

Company Announcement Copenhagen, 12 August 2025No. 48/2025 ISS increases its share buyback programme by DKK 500 million and commences second tranche ISS A/S, a leading workplace experience and facility management company, today in connection with Company Announcement no. 47/2025 announces that the Board of Directors has decided to commence the second tranche of up to DKK 1,750 million under its current share buyback programme which has been increased by DKK 500 million. Under the programme, ISS will therefore buy back own shares for a maximum consideration of  up to DKK 3,000 million, including approx. DKK 1,250 million related to the completed first tranche, over a 12- month period from 20 February 2025 to 13 February 2026 at the latest, both days inclusive. Through the share buyback programme, ISS wishes to redistribute excess cash to...

Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2Patients treated with ianalumab also experienced a significantly higher rate of sustained improvements in platelet count, the key secondary endpoint of the study1Ianalumab, administered as four once-monthly doses in the ITP setting, could offer long-term disease control through a short course of treatment and potentially allow patients extended time off treatment, if approvedData expected to be presented at an upcoming medical meeting and included in future regulatory submissions in 2027 along with results from the ongoing first-line ITP trial, VAYHIT1Basel, August 12, 2025 – Novartis today announced positive top-line results from VAYHIT2, a Phase III...